Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST

Go back to Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
APTARGROUP, Inc. (NYSE: ATR) Delayed: 124.89 -0.64 (0.51%)
Previous Close $125.53    52 Week High $81.50 
Open $126.09    52 Week Low $66.33 
Day High $127.17    P/E 49.56 
Day Low $124.40    EPS $2.52 
Volume 391,605       

(NASDAQ: MIST) Delayed: 1.28 --0 (-0%)
Previous Close $1.28    52 Week High
Open $1.29    52 Week Low
Day High $1.30    P/E N/A 
Day Low $1.26    EPS
Volume 510,198